References
-
1a
Fleisch H.
A New Class of Drugs in Diseases
of Bone and Calcium Metabolism. In Handbook
of Experimental Pharmacology
Vol. 83:
Baker
P. F., Springer;
Berlin/Heidelberg:
1988.
p.441-465
-
1b
Geddes AD.
D’Souza SM.
Ebetino FH.
Ibbotson KJ. In
Bone and Mineral Research
Elsevier
Science;
New York:
1994.
-
1c
Widler L.
Jaeggi KA.
Glatt M.
Müller K.
Bachmann R.
Bisping M.
Born A.-R.
Cortesi R.
Guiglia G.
Jeker H.
Klein R.
Ramseier U.
Schmid J.
Schreiber G.
Seltenmeyer Y.
Green JR.
J. Med. Chem.
2002,
45:
3721
-
2a
Smith R.
Russell RGG.
Bishop M.
Lancet
1971,
i:
945
-
2b
O’Doherty DP.
Bickerstaff DR.
McCloskey EV.
Hamdy NAT.
Beneton MNC.
Harris S.
Mian M.
Kanis JA.
J. Bone Miner. Res.
1990,
5:
483
- 3
Morton AR.
Cantrill JA.
Pillai GV.
McMahon A.
Anderson DC.
Howell A.
Br.
Med. J.
1988,
297:
772
-
4a
Storm T.
Thamsborg G.
Steiniche T.
Genant HK.
Sorensen OH.
N. Engl. J. Med.
1990,
322:
1265
-
4b
Reginster JY.
Deroisy R.
Denis D.
Collette J.
Lecart MP.
Sarlet N.
Ethgen D.
Franchimont P.
Lancet
1989,
ii:
1469
-
5a
Schlachter ST.
Galinet LA.
Shields SK.
Aspar DG.
Dunn CJ.
Staite ND.
Nugent RA.
Bioorg. Med. Chem. Lett.
1998,
8:
1093
-
5b
Nugent RA.
Schlachter ST.
Murphy M.
Dunn CJ.
Staite ND.
Galinet LA.
Shields SK.
Wu H.
Aspar DG.
Richard KA.
J. Med. Chem.
1994,
37:
4449
-
6a
Bijvoet OL.
Frijlink WB.
Jie K.
Van der Linden H.
Meijer CJ.
Mulder H.
Van Paassen HC.
Reitsma PH.
De velde J.
De Vries E.
Van der Wey J.
Arthritis Rheum.
1980,
23:
1193
-
6b
Ralston SH.
Willocks LJ.
Hacking L.
Pitkeathly DA.
Calc.
Int.
1988,
42:
23
- 7
Byers JH.
Thissell JG.
Thomas MA.
Tetrahedron Lett.
1995,
36:
6403
-
8a
Zard SZ.
Angew. Chem., Int. Ed.
Engl.
1997,
36:
672 ; and
references cited
-
8b
Quiclet-Sire B.
Zard SZ.
Phosphorus, Sulfur Silicon
Relat. Elem.
1999,
153 ;
and references cited
-
8c
Quiclet-Sire B.
Zard SZ.
Phosphorus, Sulfur Silicon
Relat. Elem.
1999,
137 ;
and references cited
- 9 For a synthetic study concerning
the sulfenylation of tetraalkylmethylene-bisphosphonates, see: Mikolajczyk M.
Balczewski P.
Grzejszczak S.
Synthesis
1980,
127
- 12
Liard A.
Quiclet-Sire B.
Zard SZ.
Tetrahedron
Lett.
1996,
37:
5877
- 13
Barbier F.
Pautrat F.
Zard SZ.
Synlett
2002,
811
-
14a
Ollivier C.
Renaud P.
J.
Am. Chem. Soc.
2000,
122:
6496
-
14b
Ollivier C.
Renaud P.
J. Am. Chem. Soc.
2001,
123:
4717
-
15a
Kim S.
Song H.-J.
Choi T.-L.
Yoon J.-Y.
Angew. Chem.
Int. Ed.
2001,
40:
2524
-
15b
Bertrand F.
Le Guyader F.
Liguori L.
Ouvry G.
Quiclet-Sire B.
Seguin S.
Zard SZ.
C.
R. Acad. Sci.
2001,
4:
547
-
15c
Quiclet-Sire B.
Seguin S.
Zard SZ.
Angew.
Chem. Int. Ed.
1998,
37:
2864
-
15d
Bertrand F.
Quiclet-Sire B.
Zard SZ.
Angew.
Chem. Int. Ed.
1999,
38:
1943
-
15e
Liard A.
Quiclet-Sire B.
Saicic RN.
Zard SZ.
Tetrahedron Lett.
1997,
38:
1759
-
15f
Ly T.-M.
Quiclet-Sire B.
Sortais B.
Zard SZ.
Tetrahedron Lett.
1999,
40:
2533
-
15g
Kaoudi T.
Quiclet-Sire B.
Seguin S.
Zard SZ.
Angew. Chem. Int. Ed.
2000,
39:
731
10
Procedure for
the Synthesis of Xanthate 1a: To a solution of tetramethylmethylenebis-phosphonate
(1.16 g, 5 mmol) in anhyd THF (50 mL) at r.t. under argon was added portionwise
60% NaH in mineral oil (0.4 g, 10 mmol). When the evolution
of hydrogen ceased, the reaction mixture was cooled down to -78 °C
and a solution of bis-ethoxythio-carbonyldisulfane (1.27 g, 5.25
mmol) in anhyd THF (10 mL) was added. The reaction mixture was then
slowly warmed to r.t. A 1 M HCl solution was added (50 mL) and the
mixture was extracted with diethyl ether (2 × 50
mL). The combined organic extracts were washed with sat. aq NaCl,
dried over MgSO4, filtered, and the solvents were removed
under reduced pressure. The residue was purified by flash column
chromatography (silica gel, dichloro-methane/methanol,
97:3) to give 1a (1.28 g, 73%)
as a pale yellow oil. 1H NMR (400 MHz, CDCl3): δ = 1.45
(t, J = 7.0 Hz,
3 H), 3.84-3.87 (m, 12 H), 4.70 (q, J = 7.0
Hz, 2 H), 4.91 (t, J = 21.7
Hz, 1 H). 13C NMR (50 MHz, CDCl3): δ = 13.8, 41.5
(t, J
CP
= 137 Hz), 54.4 (d, J
CP
= 9 Hz), 72.3, 211.9.
IR (CCl4): 2955, 1459, 1264, 1239, 1184, 1112, 1042 cm-1.
MS (CI + NH3): m/z = 353
(MH+), 370 (MNH4
+).
11
Typical Procedure: 352
mg (1 mmol) of xanthate 1a and 0.33 mL
(2 mmol) of allyl acetate dissolved in 1,2-dichloroethane (1 mL)
were refluxed a few minutes under argon before the addition of (20
mg, 0.05 mmol) of commercially available lauroyl peroxide. The reflux
was maintained for another 2 h. The solvent was then removed under
reduced pressure and the residue purified by flash column chromatography
(silica gel, dichloromethane/methanol, 97:3) to give 2b (370 mg, 82%) as a pale yellow oil. 1H
NMR (400 MHz, CDCl3): δ = 1.41 (t, J = 7.0 Hz,
3 H), 2.05 (s, 3 H), 2.02-2.22 (m, 1 H), 2.28-2.41
(m, 1 H), 2.66 (tdd, J = 25.0,
8.8, 3.5 Hz, 1 H), 3.78-3.82 (m, 12 H), 4.19 (dd, J = 11.1,
5.3 Hz, 1 H), 4.24-4.30 (m, 1 H), 4.34 (dd, J = 11.1,
4.1 Hz, 1 H), 4.62 (q, J = 7.0
Hz, 2 H). 13C NMR (100 MHz, CDCl3): δ = 13.8,
20.8, 26.3 (t, J
CP
= 4 Hz), 33.4 (t, J
CP
= 134 Hz), 48.5, 53.5
(d, J
CP
= 9 Hz), 65.6, 70.5,
170.6, 212.0. IR (CCl4): 2954, 1748, 1257, 1227, 1036 cm-1.
MS (CI + NH3): m/z = 453
(MH+). Anal. Calcd for C13H26O9P2S2:
C, 34.51; H, 5.79. Found: C, 34.61; H, 5.88.